Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Fibrosis Interstitial”

889 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 889 results

Not applicableLooking for participantsNCT05310669
What this trial is testing

Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Fibrosis, Pulmonary
University of Modena and Reggio Emilia 100
Not applicableStudy completedNCT01789996
What this trial is testing

The Six Minute Walk Test: Influence of Instruction on Results

Who this might be right for
Interstitial Lung Disease
Inova Health Care Services 45
Not applicableEnded earlyNCT05267418
What this trial is testing

Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise Tolerance

Who this might be right for
DyspneaLung DiseasesPulmonary Hypertension+3 more
Laval University 30
Not applicableStudy completedNCT03300583
What this trial is testing

Toward Self-management in ILD

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisConnective Tissue Related ILD+2 more
Kingston University 16
Testing effectiveness (Phase 2)UnknownNCT02809456
What this trial is testing

Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients

Who this might be right for
Radiation Pneumonitis
Taipei Medical University WanFang Hospital 50
Large-scale testing (Phase 3)Study completedNCT06383819
What this trial is testing

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

Who this might be right for
Post-Acute COVID-19 SyndromeLung Disease With PolymyositisFibrosis+2 more
NPO Petrovax 392
Testing effectiveness (Phase 2)Study completedNCT01417156
What this trial is testing

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 20
Not applicableStudy completedNCT03944928
What this trial is testing

ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Tours 30
Testing effectiveness (Phase 2)UnknownNCT05118256
What this trial is testing

Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis

Who this might be right for
SilicosisProgressive Massive FibrosisComplicated Silicosis
Instituto de investigación e innovación biomédica de Cádiz 18
Early research (Phase 1)UnknownNCT03187431
What this trial is testing

Role of Stem Cell Therapy in Interstitial Pulmonary Fibrosis

Who this might be right for
Stem Cell Transplant Complications
Assiut University 12
Not applicableNot Yet RecruitingNCT06852794
What this trial is testing

USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINIC

Who this might be right for
Interstitial Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableEnded earlyNCT02821039
What this trial is testing

Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study

Who this might be right for
Idiopathic Pulmonary FibrosisUsual Interstitial Pneumonia
Turkish Thoracic Society 1,678
Testing effectiveness (Phase 2)Study completedNCT06241560
What this trial is testing

A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 20
Not applicableStudy completedNCT03411876
What this trial is testing

Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisHypoxemia
Klaus Kenn 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT07520110
What this trial is testing

Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Massachusetts, Worcester 800
Early research (Phase 1)Study completedNCT07229716
What this trial is testing

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

Who this might be right for
Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Large-scale testing (Phase 3)Study completedNCT01619085
What this trial is testing

Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 752
Testing effectiveness (Phase 2)Study completedNCT05964335
What this trial is testing

Cough Reduction in IPF With Nalbuphine ER

Who this might be right for
Idiopathic Pulmonary Fibrosis
Trevi Therapeutics 165
Post-approval studies (Phase 4)Study completedNCT00188955
What this trial is testing

Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant

Who this might be right for
Kidney Transplantation
University of Manitoba 40
Not applicableLooking for participantsNCT04160715
What this trial is testing

Korean Idiopathic Pulmonary Fibrosis Registry

Who this might be right for
Idiopathic Pulmonary Fibrosis
Seoul National University Hospital 3,000
Next Page